Advertisement

Health


ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ

ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ

Earlier this year a Byron Bay-based company achieved a milestone ...

Could new findings put Mesoblast back in the COVID treatment race?

Could new findings put Mesoblast back in the COVID treatment race?

After four months in the doldrums due to its COVID-19 treatment i...

AnteoTech launches 15-minute COVID-19 test in Europe

AnteoTech launches 15-minute COVID-19 test in Europe

Brisbane-based biotech firm AnteoTech (ASX: ADO) has officially l...

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane and Seattle-based biotechnology company Implicit Bioscie...

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

A bet made by Mayne Pharma (ASX: MYX) in 2019 has paid off today ...

Advertisement
Advertisement
Advertisement
Starpharma's anti-COVID nasal spray approved in Europe and the UK

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Australian pharmaceutical company Starpharma's (ASX: SPL) ant...

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Mitigation measures against COVID-19 led to a drastic reduction i...

Profits double for IVF specialist Virtus Health

Profits double for IVF specialist Virtus Health

As the leading assisted reproductive services (ARS) company ...

Noxopharm study results herald "new era" for prostate cancer treatment

Noxopharm study results herald "new era" for prostate cancer treatment

A trial of Noxopharm's (ASX: NOX) prostate cancer treatment h...

What's the difference between mutations, variants and strains? A guide to COVID terminology

What's the difference between mutations, variants and strains? A guide to COVID terminology

Living through a global pandemic over the past year has seen all ...

Mesoblast rises on positive back pain trial results

Mesoblast rises on positive back pain trial results

Positive results from stem cell research company Mesoblast's ...

Eyes and ears on Healthia as shares double in four months

Eyes and ears on Healthia as shares double in four months

Investors appeared to take little notice of allied health group H...

Little Green Pharma plans $22m raise to boost cannabis production and push internationally

Little Green Pharma plans $22m raise to boost cannabis production and push internationally

Medicinal cannabis cultivator and manufacturer Little Green Phar...

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Cynata Therapeutics (ASX: CYP), founded by two clever stem cell r...

How Smiles Inclusive was turned upside down: A timeline of decay

How Smiles Inclusive was turned upside down: A timeline of decay

For retail investors there is something very reassuring about put...

AnteoTech spikes on customer Ellume's $304m US contract news

AnteoTech spikes on customer Ellume's $304m US contract news

Shares in Brisbane-based nanotechnology company AnteoTech (ASX: A...

Ellume secures $304m US Government contract to scale up COVID-19 test production

Ellume secures $304m US Government contract to scale up COVID-19 test production

Brisbane-based diagnostics company Ellume has today announced a U...

Tomas Steenackers mimics National Vet Care with new optometry venture

Tomas Steenackers mimics National Vet Care with new optometry venture

After the ASX-listed company he founded was offered a $251.5 mill...

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Medicinal cannabis company Little Green Pharma (ASX: LGP) is toda...

Immutep's EAT COVID trial progresses to the next phase

Immutep's EAT COVID trial progresses to the next phase

A trial of biotechnology company Immutep's (ASX: IMM) experim...

Advertisement

Partner Content

Australian businesses could be losing billions of dollars due to ...
With many innovative functions like copy trading, crypto investme...
Whilst some cannabis stocks can trade on hype and future earnings...
The focus on digital health has become a global trend. The long...
Food Revolution Group (ASX: FOD) could be the ASX's turnaroun...
A big shift in consumer spending habits over the past year has pl...
It took determination and ambition for Glen Richards to scale up ...
It's fair to say that at the start of 2020, few would have pr...
Momentum for cannabis stocks continues to intensify, as internati...
ESG (Environment, Social, Governance) has become essential in bus...
Advertisement